Delimiting the use of comparative genomic hybridization in human myeloid neoplastic disorders.

International journal of oncology

Volumn 16, Issue 6, 2000, Pages 1099-1105

  Gebhart, E ^a   Verdorfer, I ^a   Saul, W ^a   Trautmann, U ^a   Brecevic, L ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW CELL; CHROMOSOME DELETION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; KARYOTYPING; MALE; METHODOLOGY; MIDDLE AGED; MYELOPROLIFERATIVE DISORDER; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY;

ADULT; AGED; BONE MARROW CELLS; CHROMOSOME DELETION; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; NUCLEIC ACID HYBRIDIZATION;

MLCS; MLOWN;

EID: 0034201384     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.16.6.1099     Document Type: Article

References (0)